The tolerogenic features that ensure maternal-fetal immune success were subsequently found to have profound implications for tumor biology, transplantation, and infection, with HLA-G emerging as a central regulator of cytotoxic effector functions across these settings. The gene discussed is HLA-G; the disease is neoplasm.